Furthermore, treatment with broussonin A or B markedly suppressed VEGF‐A‐induced expression of integrin β1 and integrin‐linked kinase (ILK), a key kinase in integrin downstream signalling pathways, which are closely associated with angiogenesis and tumour progression (Figure 6C).39, 40, 41. Here, VEGFA is linked to neoplasm.